Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada
NCT06361563
·
clinicaltrials.gov ↗
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Upper Gastrointestinal Cancer
Interventions
DRUG:
Nivolumab
Sponsor
Bristol-Myers Squibb